Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature review
Despite premature study closure, the suggested beneficial effect of MSC co-transplantation for the prevention of acute GVHD in HLA-mismatched HCT warrants further investigation.
Authors
- Anika Janssen (ORCID: https://orcid.org/0000-0002-1212-8189)
- Chantal Lechanteur (ORCID: https://orcid.org/0009-0003-8842-9708)
- Joséphine Muller
- Frédéric Baron (ORCID: https://orcid.org/0000-0002-2944-3812)
- Laurence Seidel (ORCID: https://orcid.org/0000-0003-2733-269X)
- Étienne Baudoux (ORCID: https://orcid.org/0000-0002-1730-8357)
- Pierre Zachée (ORCID: https://orcid.org/0000-0002-2275-5143)
- Alexandra Briquet
- Tessa Kerre (ORCID: https://orcid.org/0000-0003-2114-2844)
- Yves Béguin (ORCID: https://orcid.org/0000-0003-4650-7520)
- Julie Herman
- Sophie Servais (ORCID: https://orcid.org/0000-0002-0238-6379)
- Gérôme Lombardo
- Évelyne Willems
Institutions
- University of Liège (BE)
- Ghent University Hospital (BE)
- Centre Hospitalier Universitaire de Liège (BE)
- Ziekenhuisnetwerk Antwerpen Stuivenberg (BE)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1186/s13287-024-04064-w
- Citations
- 9
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 3.94
Funders
- Fonds De La Recherche Scientifique - FNRS
- Université de Liège
- Fonds Léon Fredericq
- Fondation contre le Cancer